— Know what they know.
Not Investment Advice

KMTS NASDAQ

Kestra Medical Technologies, Ltd.
1W: +0.2% 1M: +8.4% 3M: +23.3% YTD: +20.6% 1Y: +14.5%
$30.01
+0.59 (+2.01%)
After Hours: $27.45 (-2.56, -8.53%)
Weekly Expected Move ±10.4%
$23 $26 $29 $32 $35
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 66 · $1.8B mcap · 34M float · 1.16% daily turnover · Short 82% of daily vol
Credit Risk of going bust: lower than 58% of companies Debt: 4.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.16 (down 99.5%), Kestra Medical Technologies, Ltd. would be worth roughly what it owes.
Total debt $76.4M against a stock market value of $1.75B.
Distance to default 6.01 (Merton model): prices to 2026-10-26, balance sheet 2026-07-31, debt counted $36.2M (short-term plus half of long-term), stock volatility 63.6%; Altman Z 5.20. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.8B
52W Range17.34-30
Volume294,072
Avg Volume391,254
Beta0.62
Dividend—
Analyst Ratings
3 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOBrian Webster
Employees443
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2025-03-06
3933 Lake Washington Blvd NE
Kirkland, WA 98033
US
425 279 8002
About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.

Recent Insider Trades

NameTypeSharesPriceDate
Umberger Traci S M-Exempt 100,000 $17.00 2026-10-21
Umberger Traci S S-Sale 96,404 $27.15 2026-10-21
Umberger Traci S S-Sale 3,596 $28.09 2026-10-21
Umberger Traci S M-Exempt 100,000 $17.00 2026-10-21
Webster Brian Daniel S-Sale 13,316 $29.52 2026-10-20

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms